Brokers' Take
S&P Global shifts Genting companies’ outlook to negative on weaker credit quality forecasts
Group capital expenditure could double in 2026, with earnings ‘unlikely’ to keep pace
Seatrium back on track with estimated S$2 billion TenneT order: analysts
The latest contract lifts the total value of its new wins in FY2025 past S$4 billion
DBS bullish on developers, hikes up target prices for CDL, UOL, GuocoLand
The increase comes on lower interest rates and plans by these firms to recycle capital and rejuvenate assets
Analysts upbeat on Singapore’s office Reits, naming one ‘uniquely leveraged’ to tap rental upside
They name a few buy-rated stocks, and expect core CBD rents to rise
UOBKH initiates coverage on UltraGreen.ai with ‘buy’ on optimistic growth outlook
The company is well-positioned to benefit from potential expansion in the fluorescence-guided surgery market, say UOBKH analysts
Analysts raise CIMB target price on ‘surprise’ capital return initiative
The bank announces it will be returning up to RM2 billion of capital to shareholders by end-2027
Aletheia Capital downgrades Wilmar to ‘sell’, cuts target to S$2.50 on legal woes
China contributes more than half of the agribusiness group’s earnings
UOB Kay Hian initiates coverage on Soon Hock; optimistic on its S$1 billion project pipeline
UOB also expects attractive dividend yields of 5.5% and 10% for 2025 and 2026, respectively
JPMorgan sees DBS at S$70 in a year’s time; with potential S$3.30 dividend for years
Its analysts also upgrade OCBC, SGX to ‘overweight’; see volatility for UOB
RHB initiates coverage on Keppel Infrastructure Trust with ‘buy’ call
The analyst sets a target price of S$0.55 and says the trust should have a ‘modestly growing’ distribution profile
